Jeonjinbio Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 36

Employees

  • Stock Symbol
  • 110020

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.53
  • (As of Friday Closing)

Jeonjinbio General Information

Description

JeonJin Bio Co Ltd is a South Korea based company engaged in the manufacturing and sale of pest control product using natural materials and other biotechnology products. It produces biological products including insect repellent, insect direction, algae damage reduction, mammalian damaging agent, parasitic damage reduction agent, pest damage reduction agent, paris segem, breed can, mosquito repellent, and bouquet garni.

Contact Information

Website
www.jjbio.co.kr
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 295, Seongseogongdanbuk-ro, Dalseo-gu
  • Dalseo-gu, Galsan-dong
  • Daegu, 42713
  • South Korea
+82
Primary Industry
Agricultural Chemicals
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 295, Seongseogongdanbuk-ro, Dalseo-gu
  • Dalseo-gu, Galsan-dong
  • Daegu, 42713
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jeonjinbio Stock Performance

As of 13-Nov-2026, Jeonjinbio’s stock price is $1.53. Its current market cap is $13.8M with 9.1M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.53 $1.51 $0.96 - $2.34 $13.8M 9.1M 16.2K -$0.02

Jeonjinbio Financials Summary

As of 30-Jun-2026, Jeonjinbio has a trailing 12-month revenue of $9.5M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 5,759 11,924 10,555 49,091
Revenue 9,450 9,623 14,125 11,993
EBITDA 101 171 4,413 (2,696)
Net Income (212) (138) 3,185 (4,925)
Total Assets 11,994 12,853 12,800 13,738
Total Debt 0 0 63 4,343
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jeonjinbio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jeonjinbio‘s full profile, request access.

Request a free trial

Jeonjinbio Patents

Jeonjinbio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020235977-A1 Antistatic composition comprising oenanthe javanica extract as active ingredient Inactive 23-May-2019
GB-202010954-D0 Composition for preventing or treating parasitic infections in fish, comprimising sophora flavescens aiton extract or fraction thereof Active 29-Jan-2018
WO-2019146827-A1 Composition for preventing or treating parasitic infections in fish, comprising helianthus tuberosus extract and sophora flavescens aiton extract Inactive 29-Jan-2018
WO-2019146825-A1 Composition for preventing or treating parasitic infections in fish, comprising jerusalem artichoke extract or fraction thereof Inactive 29-Jan-2018
GB-2583664-A Composition for preventing or treating parasitic infections in fish, comprising sophora flavescens aiton extract or fraction thereof Active 29-Jan-2018 A61P33/10
To view Jeonjinbio’s complete patent history, request access »

Jeonjinbio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jeonjinbio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Jeonjinbio‘s full profile, request access.

Request a free trial

Jeonjinbio Investments (1)

Jeonjinbio’s most recent deal was a Corporate Asset Purchase with Hyundai Textile Industry (4,008.44 SM Portfolio of Land and Building in Daegu, South Korea) for . The deal was made on 31-Mar-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hyundai Textile Industry (4,008.44 SM Portfolio of Land and Building in Daegu, South Korea) 31-Mar-2020 Corporate Asset Purchase Buildings and Property
To view Jeonjinbio’s complete investments history, request access »

Jeonjinbio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Chemicals

Industry

Rank

Percentile

Commodity Chemicals

Subindustry

Rank

Percentile

To view Jeonjinbio’s complete esg history, request access »

Jeonjinbio FAQs

  • When was Jeonjinbio founded?

    Jeonjinbio was founded in 2004.

  • Where is Jeonjinbio headquartered?

    Jeonjinbio is headquartered in Daegu, South Korea.

  • What is the size of Jeonjinbio?

    Jeonjinbio has 36 total employees.

  • What industry is Jeonjinbio in?

    Jeonjinbio’s primary industry is Agricultural Chemicals.

  • Is Jeonjinbio a private or public company?

    Jeonjinbio is a Public company.

  • What is Jeonjinbio’s stock symbol?

    The ticker symbol for Jeonjinbio is 110020.

  • What is the current stock price of Jeonjinbio?

    As of 13-Nov-2026 the stock price of Jeonjinbio is $1.53.

  • What is the current market cap of Jeonjinbio?

    The current market capitalization of Jeonjinbio is $13.8M.

  • What is Jeonjinbio’s current revenue?

    The trailing twelve month revenue for Jeonjinbio is $9.5M.

  • What is Jeonjinbio’s annual earnings per share (EPS)?

    Jeonjinbio’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process